,Set,NGenes,Direction,PValue,FDR
1,WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA,86,Up,8.8346530153302e-06,0.00726208477860142
2,WP_IRON_METABOLISM_DISORDERS,13,Up,0.000174849099306699,0.0718629798150533
3,WP_MITOCHONDRIAL_COMPLEX_I_ASSEMBLY_MODEL_OXPHOS_SYSTEM,50,Up,0.000367685498336384,0.0858661608498218
4,WP_OXIDATIVE_PHOSPHORYLATION,50,Up,0.000417840198782588,0.0858661608498218
5,WP_MITOCHONDRIAL_COMPLEX_IV_ASSEMBLY,31,Up,0.000688645358070816,0.113213296866842
6,WP_NUCLEOTIDE_GPCRS,5,Down,0.00302097367920949,0.406338468555918
7,WP_MONOAMINE_GPCRS,3,Down,0.00365698697950061,0.406338468555918
8,WP_SULFATASE_AND_AROMATASE_PATHWAY,2,Up,0.0039546322973812,0.406338468555918
9,WP_HFE_EFFECT_ON_HEPCIDIN_PRODUCTION,3,Up,0.00500253095634486,0.446959228818554
10,WP_IRON_METABOLISM_IN_PLACENTA,10,Up,0.00628619279432715,0.446959228818554
11,WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING,22,Down,0.0066355497262472,0.446959228818554
12,WP_PROSTAGLANDIN_SIGNALING,23,Down,0.00715622314260717,0.446959228818554
13,WP_INTEGRINMEDIATED_CELL_ADHESION,71,Down,0.00762409214085488,0.446959228818554
14,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,33,Down,0.00790536894056764,0.446959228818554
15,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,16,Down,0.00819584042627341,0.446959228818554
16,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,29,Down,0.00869993632736844,0.446959228818554
17,WP_IL3_SIGNALING,46,Down,0.0114026858246493,0.542609512171415
18,WP_DEVELOPMENT_OF_PULMONARY_DENDRITIC_CELLS_AND_MACROPHAGE_SUBSETS,10,Down,0.0118819601205419,0.542609512171415
19,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,11,Down,0.0146667054083609,0.609661817411234
20,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,17,Up,0.0158406334049984,0.609661817411234
21,WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,10,Down,0.0158992505249071,0.609661817411234
22,WP_HIF1A_AND_PPARG_REGULATION_OF_GLYCOLYSIS,7,Down,0.0163169829477459,0.609661817411234
23,WP_PURINERGIC_SIGNALING,14,Down,0.0181193430360312,0.647569564157288
24,WP_17P133_YWHAE_COPY_NUMBER_VARIATION,18,Down,0.0231350346527385,0.792374936856295
25,WP_DEGRADATION_PATHWAY_OF_SPHINGOLIPIDS_INCLUDING_DISEASES,14,Up,0.0257466259275663,0.827572993755504
26,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,20,Up,0.0307785192314259,0.827572993755504
27,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,13,Down,0.032507782765432,0.827572993755504
28,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,79,Down,0.0350346264369525,0.827572993755504
29,WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,12,Down,0.0355313177454128,0.827572993755504
30,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,56,Down,0.0355501018743537,0.827572993755504
31,WP_UNFOLDED_PROTEIN_RESPONSE,24,Down,0.0359606937265955,0.827572993755504
32,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,2,Down,0.0362122822642303,0.827572993755504
33,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,29,Down,0.0398921677547255,0.827572993755504
34,WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS,3,Down,0.040558655016199,0.827572993755504
35,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,129,Up,0.0419492406188147,0.827572993755504
36,WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER,24,Up,0.0421204239672373,0.827572993755504
37,WP_MALE_INFERTILITY,69,Up,0.0434847733277623,0.827572993755504
38,WP_ALTERED_GLYCOSYLATION_OF_MUC1_IN_TUMOR_MICROENVIRONMENT,8,Down,0.043795745635302,0.827572993755504
39,WP_FERROPTOSIS,51,Up,0.0441979718910952,0.827572993755504
40,WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM,31,Down,0.0456295330617219,0.827572993755504
41,WP_VALPROIC_ACID_PATHWAY,8,Down,0.0456535024771844,0.827572993755504
42,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,22,Down,0.0457388443864379,0.827572993755504
43,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,35,Down,0.0466209047298145,0.827572993755504
44,WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,19,Down,0.0469379276414732,0.827572993755504
45,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,48,Down,0.0481262257083568,0.827572993755504
46,WP_BLOOD_CLOTTING_CASCADE,7,Down,0.0485722260949928,0.827572993755504
47,WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME,16,Down,0.0489649001828192,0.827572993755504
48,WP_ANGIOGENESIS,14,Up,0.049440935294556,0.827572993755504
49,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,24,Down,0.0509962712725799,0.827572993755504
50,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_PATHWAY,5,Up,0.0517889880102722,0.827572993755504
51,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,16,Up,0.051802431030099,0.827572993755504
52,WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA,36,Down,0.0523525494833165,0.827572993755504
53,WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,31,Down,0.0535293735933017,0.830210284786679
54,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,12,Up,0.0554219619440078,0.842984494415181
55,WP_COMPLEMENT_ACTIVATION,13,Up,0.0587017697800742,0.842984494415181
56,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,8,Down,0.0592478378964053,0.842984494415181
57,WP_MAMMARY_GLAND_DEVELOPMENT_INVOLUTION_STAGE_4_OF_4,8,Up,0.059576305943365,0.842984494415181
58,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,25,Down,0.0606570946458243,0.842984494415181
59,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY,48,Down,0.0646692898915052,0.842984494415181
60,WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY,13,Down,0.0647385526672067,0.842984494415181
61,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,17,Up,0.0657270162213043,0.842984494415181
62,WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS,86,Up,0.0658903560672029,0.842984494415181
63,WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING,22,Down,0.0691156349752403,0.842984494415181
64,WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2,16,Up,0.0697617602705987,0.842984494415181
65,WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,19,Down,0.0701625438558738,0.842984494415181
66,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,53,Down,0.0743406523805565,0.842984494415181
67,WP_MITOCHONDRIAL_COMPLEX_III_ASSEMBLY,15,Up,0.0744926165898186,0.842984494415181
68,WP_DRAVET_SYNDROME,13,Up,0.076538904568006,0.842984494415181
69,WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION,5,Up,0.0765876039328342,0.842984494415181
70,WP_NEPHROGENESIS,4,Down,0.0770854337994574,0.842984494415181
71,WP_OXIDATIVE_DAMAGE_RESPONSE,35,Up,0.0784494280352644,0.842984494415181
72,WP_MAPK_SIGNALING,163,Down,0.0787791976057275,0.842984494415181
73,WP_IL1_SIGNALING,53,Down,0.0794842127275216,0.842984494415181
74,WP_FLUOROPYRIMIDINE_ACTIVITY,25,Up,0.0798491287935365,0.842984494415181
75,WP_RAC1PAK1P38MMP2_PATHWAY,50,Down,0.0810572481201543,0.842984494415181
76,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,21,Down,0.0813350789749581,0.842984494415181
77,WP_WHITE_FAT_CELL_DIFFERENTIATION,23,Down,0.084236851859856,0.842984494415181
78,WP_TCA_CYCLE_IN_SENESCENCE,10,Up,0.0848907513866396,0.842984494415181
79,WP_GABA_METABOLISM_AKA_GHB,4,Down,0.0855108211278165,0.842984494415181
80,WP_FTO_OBESITY_VARIANT_MECHANISM,2,Up,0.0879153386491644,0.842984494415181
81,WP_GENES_CONTROLLING_NEPHROGENESIS,13,Up,0.0883889051826271,0.842984494415181
82,WP_G1_TO_S_CELL_CYCLE_CONTROL,53,Up,0.089291589465246,0.842984494415181
83,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,34,Down,0.0896215660863649,0.842984494415181
84,WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION,19,Down,0.0897560463839402,0.842984494415181
85,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,10,Up,0.0901062375725019,0.842984494415181
86,WP_FOLATEALCOHOL_AND_CANCER_PATHWAY_HYPOTHESES,6,Down,0.0909575260322702,0.842984494415181
87,WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY,42,Down,0.0921425527052308,0.842984494415181
88,WP_GLIAL_CELL_DIFFERENTIATION,4,Down,0.0927950159618885,0.842984494415181
89,WP_TGIF_DISRUPTION_OF_SHH_SIGNALING,3,Down,0.0935842394525198,0.842984494415181
90,WP_EDA_SIGNALING_IN_HAIR_FOLLICLE_DEVELOPMENT,4,Up,0.0950286101206635,0.842984494415181
91,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,18,Up,0.0951458566116325,0.842984494415181
92,WP_TRIACYLGLYCERIDE_SYNTHESIS,18,Down,0.0957605529678744,0.842984494415181
93,WP_ACTIVATION_OF_NLRP3_INFLAMMASOME_BY_SARSCOV2,7,Down,0.0973424965932065,0.842984494415181
94,WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE,3,Up,0.098752520196774,0.842984494415181
95,WP_H19_RBE2F1_AND_CDKBETACATENIN_IN_COLORECTAL_CANCER,10,Down,0.102355057567195,0.842984494415181
96,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,40,Down,0.102647978933101,0.842984494415181
97,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,52,Down,0.103398142444874,0.842984494415181
98,WP_HEMESYNTHESIS_DEFECTS_AND_PORPHYRIAS,8,Up,0.108377693142363,0.842984494415181
99,WP_HEME_BIOSYNTHESIS,8,Up,0.108377693142363,0.842984494415181
100,WP_TLR4_SIGNALING_AND_TOLERANCE,27,Down,0.108607696745683,0.842984494415181
101,WP_10Q22Q23_COPY_NUMBER_VARIATION,27,Down,0.109700402473793,0.842984494415181
102,WP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES,15,Down,0.109889732624828,0.842984494415181
103,WP_INTERLEUKIN1_INDUCED_ACTIVATION_OF_NFKB,9,Down,0.110865542361513,0.842984494415181
104,WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,12,Up,0.111321898203666,0.842984494415181
105,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY,23,Down,0.111797762824716,0.842984494415181
106,WP_CREATINE_PATHWAY,2,Down,0.112695832229487,0.842984494415181
107,WP_TNFALPHA_SIGNALING,85,Down,0.112971470332661,0.842984494415181
108,WP_NRXN1_DELETION_SYNDROME,2,Up,0.113840343666316,0.842984494415181
109,WP_STEROID_HORMONE_PRECURSOR_BIOSYNTHESIS,2,Up,0.115859748918576,0.842984494415181
110,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,40,Down,0.116045654916693,0.842984494415181
111,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,1,Down,0.116123747673019,0.842984494415181
112,WP_CHEMOKINE_SIGNALING,109,Down,0.117086157874866,0.842984494415181
113,WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,14,Down,0.117127127530875,0.842984494415181
114,WP_CCL18_SIGNALING,21,Up,0.119243988557499,0.842984494415181
115,WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4,8,Up,0.11985827189319,0.842984494415181
116,WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE,4,Up,0.119862507586183,0.842984494415181
117,WP_DEVELOPMENT_AND_HETEROGENEITY_OF_THE_ILC_FAMILY,13,Down,0.121019077191834,0.842984494415181
118,WP_PHASE_I_BIOTRANSFORMATIONS_NONP450,5,Up,0.121153077893681,0.842984494415181
119,WP_CYTOSINE_METHYLATION,7,Up,0.122851984917939,0.842984494415181
120,WP_BREAST_CANCER_PATHWAY,87,Up,0.123063429841632,0.842984494415181
121,WP_MEASLES_VIRUS_INFECTION,102,Down,0.127427250371358,0.855850685201045
122,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,5,Up,0.127705924173273,0.855850685201045
123,WP_PROSURVIVAL_SIGNALING_OF_NEUROPROTECTIN_D1,15,Down,0.13015001155923,0.855850685201045
124,WP_13Q1212_COPY_NUMBER_VARIATION,21,Down,0.130845869217929,0.855850685201045
125,WP_PROXIMAL_TUBULE_TRANSPORT,25,Down,0.134021616256938,0.855850685201045
126,WP_IDO_METABOLIC_PATHWAY,8,Down,0.135217715540157,0.855850685201045
127,WP_GPCRS_CLASS_B_SECRETINLIKE,4,Up,0.135682693304584,0.855850685201045
128,WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,40,Down,0.136987891991926,0.855850685201045
129,WP_NEURAL_CREST_DIFFERENTIATION,40,Up,0.137723479767295,0.855850685201045
130,WP_METASTATIC_BRAIN_TUMOR,6,Up,0.143563403891834,0.855850685201045
131,WP_AMINO_ACID_TRANSPORT_DEFECTS_IEMS,2,Down,0.145675012642923,0.855850685201045
132,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,12,Down,0.145698268908712,0.855850685201045
133,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,20,Down,0.145766773915956,0.855850685201045
134,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,21,Down,0.145989300371459,0.855850685201045
135,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,13,Down,0.146189750528738,0.855850685201045
136,WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME,27,Down,0.149071378187293,0.855850685201045
137,WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,7,Down,0.150362131258281,0.855850685201045
138,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,15,Up,0.150605401222517,0.855850685201045
139,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,8,Down,0.151761829840196,0.855850685201045
140,WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,113,Up,0.153840250129616,0.855850685201045
141,WP_15Q25_COPY_NUMBER_VARIATION,27,Up,0.155986408582902,0.855850685201045
142,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,8,Up,0.156808135093067,0.855850685201045
143,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,16,Down,0.156891583093944,0.855850685201045
144,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,12,Up,0.157327347011795,0.855850685201045
145,WP_7OXOC_AND_7BETAHC_PATHWAYS,17,Up,0.157841120042944,0.855850685201045
146,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,21,Down,0.162489852663977,0.855850685201045
147,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,21,Up,0.162530269038623,0.855850685201045
148,WP_BENZOAPYRENE_METABOLISM,5,Up,0.162790788094852,0.855850685201045
149,WP_KREBS_CYCLE_DISORDERS,11,Down,0.163833379852702,0.855850685201045
150,WP_COVID19_STRUCTURAL_COVERAGE_MAP,19,Down,0.164612284610143,0.855850685201045
151,WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE,29,Up,0.164901598503044,0.855850685201045
152,WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY,37,Up,0.165307277319335,0.855850685201045
153,WP_GLP1_IN_PANCREATIC_ISLET_CELLS,2,Down,0.165623314652301,0.855850685201045
154,WP_LIPID_METABOLISM_PATHWAY,23,Down,0.165892763190773,0.855850685201045
155,WP_NRF2ARE_REGULATION,20,Down,0.166334630720376,0.855850685201045
156,WP_HUNGER_AND_SATIETY,2,Down,0.166786844427042,0.855850685201045
157,WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING,48,Up,0.167066602757252,0.855850685201045
158,WP_TYPE_II_INTERFERON_SIGNALING,30,Down,0.170276736886424,0.855850685201045
159,WP_OREXIN_RECEPTOR_PATHWAY,120,Down,0.171098228841053,0.855850685201045
160,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,8,Down,0.171859556963064,0.855850685201045
161,WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,14,Down,0.172439691327437,0.855850685201045
162,WP_CHOLESTEROL_SYNTHESIS_DISORDERS,17,Up,0.172725538002694,0.855850685201045
163,WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,13,Down,0.173957053529559,0.855850685201045
164,WP_CYTOSOLIC_DNASENSING_PATHWAY,54,Down,0.175286248015571,0.855850685201045
165,WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,5,Up,0.177211447023614,0.855850685201045
166,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,10,Up,0.17741052374617,0.855850685201045
167,WP_DISORDERS_IN_KETOLYSIS,3,Down,0.179265027262365,0.855850685201045
168,WP_COMPLEMENT_SYSTEM,52,Up,0.181494293354081,0.855850685201045
169,WP_SOMATROPH_AXIS_GH_AND_ITS_RELATIONSHIP_TO_DIETARY_RESTRICTION_AND_AGING,6,Up,0.182799630095116,0.855850685201045
170,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,32,Down,0.183559966038199,0.855850685201045
171,WP_INFLAMMATORY_RESPONSE_PATHWAY,14,Up,0.186254094526968,0.855850685201045
172,WP_RETINOL_METABOLISM,6,Down,0.188072018820192,0.855850685201045
173,WP_WNT_SIGNALING_WP428,60,Up,0.188799787193531,0.855850685201045
174,WP_RANKLRANK_SIGNALING,48,Down,0.188938626718473,0.855850685201045
175,WP_G13_SIGNALING,29,Down,0.191996384465539,0.855850685201045
176,WP_ESTROGEN_RECEPTOR_PATHWAY,8,Up,0.19250971882345,0.855850685201045
177,WP_MESODERMAL_COMMITMENT_PATHWAY,76,Up,0.194557026729928,0.855850685201045
178,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,18,Up,0.194934010141012,0.855850685201045
179,WP_SARSCOV2_ALTERING_ANGIOGENESIS_VIA_NRP1,3,Up,0.196483687780594,0.855850685201045
180,WP_NOTCH_SIGNALING_WP268,36,Down,0.198894998378898,0.855850685201045
181,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,30,Down,0.198965189976442,0.855850685201045
182,WP_EV_RELEASE_FROM_CARDIAC_CELLS_AND_THEIR_FUNCTIONAL_EFFECTS,3,Down,0.201308582937434,0.855850685201045
183,WP_ASPIRIN_AND_MIRNAS,8,Up,0.205026980575839,0.855850685201045
184,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,37,Down,0.205453692082333,0.855850685201045
185,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,13,Up,0.20638965595115,0.855850685201045
186,WP_PYRIMIDINE_METABOLISM,71,Up,0.208202304457168,0.855850685201045
187,WP_AGERAGE_PATHWAY,54,Down,0.208731089160153,0.855850685201045
188,WP_WNT_SIGNALING_IN_KIDNEY_DISEASE,14,Up,0.209381791189691,0.855850685201045
189,WP_ETHER_LIPID_BIOSYNTHESIS,16,Down,0.209396577145949,0.855850685201045
190,WP_ZINC_HOMEOSTASIS,24,Up,0.209426232681799,0.855850685201045
191,WP_NPHP1_DELETION_SYNDROME,10,Down,0.209611875615961,0.855850685201045
192,WP_OPIOID_RECEPTOR_PATHWAYS,26,Down,0.209692198169283,0.855850685201045
193,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,101,Down,0.210181456052392,0.855850685201045
194,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,23,Down,0.211145639769189,0.855850685201045
195,WP_TYPE_II_DIABETES_MELLITUS,14,Down,0.21135410607367,0.855850685201045
196,WP_NSP1_FROM_SARSCOV2_INHIBITS_TRANSLATION_INITIATION_IN_THE_HOST_CELL,16,Down,0.21356259928392,0.855850685201045
197,WP_OSTEOCLAST_SIGNALING,9,Up,0.214548381807279,0.855850685201045
198,WP_FOCAL_ADHESION,118,Down,0.215804816834164,0.855850685201045
199,WP_15Q112_COPY_NUMBER_VARIATION_SYNDROME,9,Down,0.216274688426645,0.855850685201045
200,WP_PAFAH1B1_COPY_NUMBER_VARIATION,8,Down,0.218294830196969,0.855850685201045
201,WP_HEDGEHOG_SIGNALING_WP47,6,Up,0.218706343408425,0.855850685201045
202,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,60,Up,0.219227890200993,0.855850685201045
203,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,60,Up,0.220950184240862,0.855850685201045
204,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,47,Down,0.221365862980481,0.855850685201045
205,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,44,Up,0.22157074963406,0.855850685201045
206,WP_KALLMANN_SYNDROME,11,Up,0.222009941942906,0.855850685201045
207,WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,10,Up,0.223268790383206,0.855850685201045
208,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,40,Down,0.224151869040559,0.855850685201045
209,WP_AMINO_ACID_METABOLISM_PATHWAY_EXCERPT_HISTIDINE_CATABOLISM_EXTENSION,2,Down,0.224582600117866,0.855850685201045
210,WP_VEGFAVEGFR2_SIGNALING,341,Down,0.225775267689501,0.855850685201045
211,WP_TAMOXIFEN_METABOLISM,2,Up,0.226314473677092,0.855850685201045
212,WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA,21,Up,0.226815403703071,0.855850685201045
213,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,20,Down,0.227229509816763,0.855850685201045
214,WP_8P231_COPY_NUMBER_VARIATION_SYNDROME,32,Up,0.227451573410878,0.855850685201045
215,WP_LEPTIN_AND_ADIPONECTIN,8,Up,0.227649723770412,0.855850685201045
216,WP_VASOPRESSINREGULATED_WATER_REABSORPTION,34,Down,0.229035055213565,0.855850685201045
217,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,16,Down,0.229382325697848,0.855850685201045
218,WP_ATR_SIGNALING,10,Up,0.231319560734353,0.855850685201045
219,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM,4,Down,0.232520226285311,0.855850685201045
220,WP_HIJACK_OF_UBIQUITINATION_BY_SARSCOV2,8,Up,0.232752686959736,0.855850685201045
221,WP_ULCERATIVE_COLITIS_SIGNALING,13,Up,0.23588032901515,0.855850685201045
222,WP_OSTEOBLAST_SIGNALING,3,Up,0.238785752479462,0.855850685201045
223,WP_REGULATION_OF_ACTIN_CYTOSKELETON,89,Down,0.239289851343569,0.855850685201045
224,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING,105,Down,0.239432498265768,0.855850685201045
225,WP_AFLATOXIN_B1_METABOLISM,2,Down,0.239470340777386,0.855850685201045
226,WP_TARGET_OF_RAPAMYCIN_SIGNALING,32,Up,0.239709635788571,0.855850685201045
227,WP_TRANSLATION_FACTORS,49,Down,0.240378701154968,0.855850685201045
228,WP_SCFA_AND_SKELETAL_MUSCLE_SUBSTRATE_METABOLISM,2,Down,0.241317183524353,0.855850685201045
229,WP_CEREBRAL_ORGANIC_ACIDURIAS_INCLUDING_DISEASES,7,Up,0.241844322945709,0.855850685201045
230,WP_RETT_SYNDROME,30,Down,0.241882723045854,0.855850685201045
231,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,19,Down,0.243041196377506,0.855850685201045
232,WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE,14,Up,0.243200525645121,0.855850685201045
233,WP_FATTY_ACID_TRANSPORTERS,10,Up,0.244160316654791,0.855850685201045
234,WP_LEPTININSULIN_SIGNALING_OVERLAP,12,Up,0.244444377787433,0.855850685201045
235,WP_DUAL_HIJACK_MODEL_OF_VIF_IN_HIV_INFECTION,8,Up,0.244823986489549,0.855850685201045
236,WP_UREA_CYCLE_AND_RELATED_DISEASES,3,Up,0.245884640431791,0.855850685201045
237,WP_PURINE_METABOLISM,10,Up,0.246759869090812,0.855850685201045
238,WP_HEPATITIS_B_INFECTION,116,Down,0.249339601612204,0.859017357735894
239,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,8,Down,0.249762954378198,0.859017357735894
240,WP_DNA_DAMAGE_RESPONSE,59,Up,0.250868049151202,0.85902226059758
241,WP_GLYCOLYSIS_IN_SENESCENCE,10,Down,0.251941140109719,0.85902226059758
242,WP_DISORDERS_IN_KETONE_BODY_SYNTHESIS,2,Down,0.258894172243836,0.85902226059758
243,WP_PROTEOGLYCAN_BIOSYNTHESIS,15,Down,0.259503472661686,0.85902226059758
244,WP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR,88,Up,0.26256100785131,0.85902226059758
245,WP_INTERFERONMEDIATED_SIGNALING,15,Up,0.26294208084651,0.85902226059758
246,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,19,Down,0.263622521351012,0.85902226059758
247,WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,18,Up,0.264974351590765,0.85902226059758
248,WP_RALA_DOWNSTREAM_REGULATED_GENES,11,Down,0.265560635884034,0.85902226059758
249,WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,7,Down,0.268617594365169,0.85902226059758
250,WP_PROLINE_AND_HYDROXYPROLINE_PATHWAYS,3,Up,0.269224766066554,0.85902226059758
251,WP_DNA_REPLICATION,35,Up,0.270878933416189,0.85902226059758
252,WP_BIOTIN_METABOLISM_INCLUDING_IMDS,9,Up,0.271513635306041,0.85902226059758
253,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,3,Up,0.27192410973131,0.85902226059758
254,WP_TP53_NETWORK,16,Up,0.274707759353342,0.85902226059758
255,WP_RIBOFLAVIN_AND_COQ_DISORDERS,13,Up,0.27504426956768,0.85902226059758
256,WP_CANONICAL_NFKB_PATHWAY,8,Down,0.277487221539058,0.85902226059758
257,WP_ARYLAMINE_METABOLISM,1,Up,0.277807556182753,0.85902226059758
258,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,6,Up,0.279832013082351,0.85902226059758
259,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,21,Down,0.280331693107781,0.85902226059758
260,WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,25,Down,0.281330574310862,0.85902226059758
261,WP_CHOLESTEROL_METABOLISM,52,Up,0.28238390340578,0.85902226059758
262,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,58,Down,0.282853654742157,0.85902226059758
263,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,7,Down,0.283522663735922,0.85902226059758
264,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,17,Down,0.283778151568836,0.85902226059758
265,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,48,Down,0.284568021500855,0.85902226059758
266,WP_GLYOXYLATE_METABOLISM,5,Down,0.284723969310939,0.85902226059758
267,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,20,Down,0.285453927282683,0.85902226059758
268,WP_DISORDERS_OF_GALACTOSE_METABOLISM,9,Down,0.285639652384391,0.85902226059758
269,WP_CELL_CYCLE,95,Up,0.285785166560611,0.85902226059758
270,WP_COVID19_ADVERSE_OUTCOME_PATHWAY,9,Down,0.287975691337439,0.85902226059758
271,WP_GALANIN_RECEPTOR_PATHWAY,12,Up,0.287982347750455,0.85902226059758
272,WP_PRION_DISEASE_PATHWAY,28,Up,0.292907428330256,0.85902226059758
273,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,14,Down,0.294505364849026,0.85902226059758
274,WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS,4,Down,0.294594806850241,0.85902226059758
275,WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING,15,Down,0.294784148865852,0.85902226059758
276,WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING,79,Up,0.295744903520209,0.85902226059758
277,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,14,Up,0.296130747172653,0.85902226059758
278,WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,11,Down,0.296169093799358,0.85902226059758
279,WP_MARKERS_OF_KIDNEY_CELL_LINEAGE,14,Down,0.296627902931237,0.85902226059758
280,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,13,Down,0.297900831898814,0.85902226059758
281,WP_CODEINE_AND_MORPHINE_METABOLISM,1,Up,0.298044970341063,0.85902226059758
282,WP_CARDIAC_PROGENITOR_DIFFERENTIATION,12,Down,0.298842418019783,0.85902226059758
283,WP_GPR40_PATHWAY,8,Down,0.300148130712743,0.85902226059758
284,WP_GASTRIN_SIGNALING,92,Down,0.30133705296224,0.85902226059758
285,WP_TCELL_RECEPTOR_SIGNALING,73,Down,0.302412003784118,0.85902226059758
286,WP_ONECARBON_METABOLISM,22,Up,0.303094071249138,0.85902226059758
287,WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE,4,Down,0.303324011959516,0.85902226059758
288,WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,4,Up,0.304638750098386,0.85902226059758
289,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,10,Up,0.305864209152539,0.85902226059758
290,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,4,Up,0.307500074007336,0.85902226059758
291,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,10,Up,0.308094426104619,0.85902226059758
292,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,48,Up,0.30826612160847,0.85902226059758
293,WP_TAR_SYNDROME,44,Down,0.308280192388578,0.85902226059758
294,WP_HOMOLOGOUS_RECOMBINATION,11,Down,0.30903567023449,0.85902226059758
295,WP_NUCLEOTIDE_EXCISION_REPAIR,43,Up,0.309791485187045,0.85902226059758
296,WP_BENZENE_METABOLISM,3,Down,0.310810709557114,0.85902226059758
297,WP_LIVER_X_RECEPTOR_PATHWAY,5,Down,0.312156339729171,0.85902226059758
298,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,10,Up,0.313189367358601,0.85902226059758
299,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,15,Up,0.313614665909121,0.85902226059758
300,WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS,24,Down,0.314139119358938,0.85902226059758
301,WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,12,Down,0.314556813187192,0.85902226059758
302,WP_VITAMIN_B12_DISORDERS,9,Down,0.320646939435352,0.871013476801076
303,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,47,Down,0.321775086038052,0.871013476801076
304,WP_TGFB_SMAD_SIGNALING,8,Down,0.322711526183543,0.871013476801076
305,WP_ENERGY_METABOLISM,41,Down,0.325525355997934,0.871013476801076
306,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,11,Down,0.326186645430372,0.871013476801076
307,WP_ACUTE_VIRAL_MYOCARDITIS,67,Down,0.326654421401227,0.871013476801076
308,WP_MITOCHONDRIAL_GENE_EXPRESSION,16,Down,0.326860400692307,0.871013476801076
309,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,56,Up,0.327424774125952,0.871013476801076
310,WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES,13,Down,0.329757958443939,0.87402772433843
311,WP_OSTEOPONTIN_SIGNALING,11,Down,0.330684455315391,0.87402772433843
312,WP_MTHFR_DEFICIENCY,18,Up,0.332162316838378,0.87499221872108
313,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,16,Up,0.333178302262406,0.87499221872108
314,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,3,Up,0.335923136480455,0.879215049733907
315,WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,16,Down,0.336925475262994,0.879215049733907
316,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,19,Down,0.340439602763748,0.885478653504808
317,WP_MELANOMA,54,Up,0.341590198938701,0.885478653504808
318,WP_INDUCTION_OF_AUTOPHAGY_AND_TOLLLIKE_RECEPTOR_SIGNALING_BY_GRAPHENE_OXIDE,8,Down,0.343270648240257,0.885478653504808
319,WP_ESTROGEN_METABOLISM_WP697,5,Up,0.343634659936781,0.885478653504808
320,WP_ADHD_AND_AUTISM_ASD_PATHWAYS,172,Up,0.344947224646399,0.886083183310437
321,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,52,Up,0.346191466535661,0.886508989072628
322,WP_THIAMINE_METABOLIC_PATHWAYS,9,Down,0.347500350732507,0.887097168640126
323,WP_RETINOBLASTOMA_GENE_IN_CANCER,71,Up,0.352743074061548,0.8955953026176
324,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,13,Down,0.353008367455112,0.8955953026176
325,WP_GDNFRET_SIGNALING_AXIS,4,Up,0.357868370565309,0.90012133581163
326,WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,9,Down,0.358379967235062,0.90012133581163
327,WP_CONVERSION_OF_ANGIOTENSINOGEN_TO_ANGIOTENSIN_II,2,Down,0.361350641453139,0.90012133581163
328,WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS,2,Up,0.361454826443459,0.90012133581163
329,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,7,Up,0.361558853160768,0.90012133581163
330,WP_ID_SIGNALING,12,Up,0.362017941515856,0.90012133581163
331,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,76,Up,0.362920098903791,0.90012133581163
332,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,38,Down,0.363552656313213,0.90012133581163
333,WP_AUTOPHAGY_IN_PANCREATIC_DUCTAL_ADENOCARCINOMA,20,Up,0.364810102113388,0.900522234045662
334,WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION,20,Down,0.367506940903127,0.903016229012852
335,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING,63,Down,0.368017562918863,0.903016229012852
336,WP_IL17_SIGNALING,25,Down,0.373370875505245,0.913425177575331
337,WP_EUKARYOTIC_TRANSCRIPTION_INITIATION,42,Down,0.376471633995507,0.918277991526134
338,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,8,Up,0.380499588014818,0.925041643447652
339,WP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING,19,Up,0.383151715182492,0.925041643447652
340,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,26,Down,0.383728832443584,0.925041643447652
341,WP_CANNABINOID_RECEPTOR_SIGNALING,17,Down,0.385954342632087,0.925041643447652
342,WP_EXRNA_MECHANISM_OF_ACTION_AND_BIOGENESIS,6,Up,0.387282999471297,0.925041643447652
343,WP_EFFECTS_OF_MFN2_MUTATION,17,Up,0.388083668813258,0.925041643447652
344,WP_BIOGENIC_AMINE_SYNTHESIS,1,Up,0.389316784543335,0.925041643447652
345,WP_NEUROTRANSMITTER_DISORDERS,1,Up,0.389316784543335,0.925041643447652
346,WP_APOPTOSIS_MODULATION_AND_SIGNALING,78,Down,0.390604010139329,0.925041643447652
347,WP_ALLOGRAFT_REJECTION,52,Up,0.391425433530127,0.925041643447652
348,WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS,10,Up,0.393078582011969,0.925041643447652
349,WP_FATTY_ACID_OMEGAOXIDATION,2,Down,0.395032519236017,0.925041643447652
350,WP_ECTODERM_DIFFERENTIATION,77,Up,0.397818358922354,0.925041643447652
351,WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,63,Down,0.398621137806382,0.925041643447652
352,WP_SERINE_METABOLISM,5,Up,0.399248511586142,0.925041643447652
353,WP_DNA_MISMATCH_REPAIR,21,Up,0.39995326860026,0.925041643447652
354,WP_SPHINGOLIPID_PATHWAY,21,Down,0.400052762032683,0.925041643447652
355,WP_MIRNA_BIOGENESIS,6,Up,0.400662859704269,0.925041643447652
356,WP_MRNA_PROTEIN_AND_METABOLITE_INDUCATION_PATHWAY_BY_CYCLOSPORIN_A,6,Down,0.401478526503505,0.925041643447652
357,WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS,20,Up,0.402595413486518,0.925041643447652
358,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,57,Down,0.403182924626857,0.925041643447652
359,WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID,2,Up,0.404002372259984,0.925041643447652
360,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,31,Down,0.408289076315756,0.929593751234256
361,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,18,Up,0.408725882242895,0.929593751234256
362,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,28,Up,0.409527750502292,0.929593751234256
363,WP_BIOSYNTHESIS_AND_TURNOVER_OF_1DEOXYSPHINGOID_BASES,7,Down,0.411432708097072,0.929593751234256
364,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,27,Up,0.412353562882924,0.929593751234256
365,WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS,12,Down,0.413094519980315,0.929593751234256
366,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,10,Down,0.41612592273853,0.929593751234256
367,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,7,Down,0.416143412172862,0.929593751234256
368,WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE,4,Up,0.421336164025767,0.929593751234256
369,WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING,50,Up,0.421813159540697,0.929593751234256
370,WP_16P112_DISTAL_DELETION_SYNDROME,21,Up,0.422557998135753,0.929593751234256
371,WP_OXIDATION_BY_CYTOCHROME_P450,15,Down,0.4243303296872,0.929593751234256
372,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,43,Up,0.424949538337663,0.929593751234256
373,WP_TRYPTOPHAN_METABOLISM,19,Down,0.425269707743615,0.929593751234256
374,WP_MICROTUBULE_CYTOSKELETON_REGULATION,35,Down,0.425555727056106,0.929593751234256
375,WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE,18,Down,0.428555379545046,0.929593751234256
376,WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY,14,Up,0.43145017181775,0.929593751234256
377,WP_SLEEP_REGULATION,11,Up,0.432535525376851,0.929593751234256
378,WP_SELENIUM_MICRONUTRIENT_NETWORK,53,Up,0.432714487468237,0.929593751234256
379,WP_PILOCYTIC_ASTROCYTOMA,6,Up,0.433811333368809,0.929593751234256
380,WP_PREGNANE_X_RECEPTOR_PATHWAY,13,Down,0.434384479026086,0.929593751234256
381,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,33,Down,0.435365803559579,0.929593751234256
382,WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER,30,Up,0.437422338598758,0.929593751234256
383,WP_ALPHA_6_BETA_4_SIGNALING,26,Down,0.438437402954382,0.929593751234256
384,WP_ENDOMETRIAL_CANCER,48,Up,0.438922661234451,0.929593751234256
385,WP_ADIPOGENESIS,87,Down,0.440704909919369,0.929593751234256
386,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,17,Down,0.441220528757126,0.929593751234256
387,WP_GANGLIO_SPHINGOLIPID_METABOLISM,6,Down,0.443993963043993,0.929593751234256
388,WP_PRIMARY_OVARIAN_INSUFFICIENCY,91,Up,0.444371938353063,0.929593751234256
389,WP_NUCLEAR_RECEPTORS,20,Down,0.445374538342546,0.929593751234256
390,WP_NGLYCAN_BIOSYNTHESIS,52,Down,0.445729738306094,0.929593751234256
391,WP_SARSCOV2_AND_ACE2_RECEPTOR_MOLECULAR_MECHANISMS,1,Up,0.446636041579959,0.929593751234256
392,WP_FLUOROACETIC_ACID_TOXICITY,6,Down,0.44981007693465,0.929593751234256
393,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,41,Up,0.451497641784557,0.929593751234256
394,WP_MITOCHONDRIAL_BETAOXIDATION,8,Down,0.451614196325329,0.929593751234256
395,WP_NOTCH_SIGNALING_WP61,49,Down,0.452192823235783,0.929593751234256
396,WP_FRAGILE_X_SYNDROME,83,Down,0.452265230986303,0.929593751234256
397,WP_MELATONIN_METABOLISM_AND_EFFECTS,20,Up,0.452617263851278,0.929593751234256
398,WP_IL18_SIGNALING,193,Down,0.45331182806275,0.929593751234256
399,WP_ALZHEIMERS_DISEASE,184,Down,0.457304328906965,0.929593751234256
400,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,184,Down,0.457304328906965,0.929593751234256
401,WP_IL7_SIGNALING,23,Up,0.458831843496947,0.929593751234256
402,WP_ENDOCHONDRAL_OSSIFICATION,27,Up,0.459018162439778,0.929593751234256
403,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,27,Up,0.459018162439778,0.929593751234256
404,WP_MIR517_RELATIONSHIP_WITH_ARCN1_AND_USP1,4,Down,0.460404800961585,0.929593751234256
405,WP_TH17_CELL_DIFFERENTIATION_PATHWAY,47,Down,0.461622303062136,0.929593751234256
406,WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME,41,Up,0.462023141322286,0.929593751234256
407,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_DIABETIC_CONDITION,6,Up,0.4626106030701,0.929593751234256
408,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_NORMAL_CONDITION,6,Up,0.4626106030701,0.929593751234256
409,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,71,Down,0.462872563850167,0.929593751234256
410,WP_SMALL_LIGAND_GPCRS,7,Up,0.463665982975724,0.929593751234256
411,WP_THERMOGENESIS,73,Down,0.466566346131056,0.932337874504909
412,WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,12,Down,0.468718982104783,0.932337874504909
413,WP_SPINA_BIFIDA,10,Up,0.469363254490702,0.932337874504909
414,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,90,Down,0.4695716302251,0.932337874504909
415,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,7,Down,0.472231258475426,0.934055287085961
416,WP_CALORIC_RESTRICTION_AND_AGING,7,Up,0.473304950878206,0.934055287085961
417,WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,21,Down,0.473845565346528,0.934055287085961
418,WP_B_CELL_RECEPTOR_SIGNALING,85,Down,0.47678046841021,0.937592212998068
419,WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS,14,Up,0.4810502512276,0.938615574617693
420,WP_DDX1_AS_A_REGULATORY_COMPONENT_OF_THE_DROSHA_MICROPROCESSOR,7,Up,0.483998108409149,0.938615574617693
421,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD,9,Down,0.48411519603047,0.938615574617693
422,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,30,Down,0.485478441026391,0.938615574617693
423,WP_PARKINSONS_DISEASE_PATHWAY,27,Up,0.486302241481967,0.938615574617693
424,WP_OVARIAN_INFERTILITY,21,Up,0.486739270890981,0.938615574617693
425,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,14,Down,0.487358499931455,0.938615574617693
426,WP_TGFBETA_RECEPTOR_SIGNALING,35,Down,0.49041012055513,0.938615574617693
427,WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA,5,Up,0.490546424281113,0.938615574617693
428,WP_INTEGRATED_CANCER_PATHWAY,40,Up,0.492486039916289,0.938615574617693
429,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,37,Down,0.494334131112722,0.938615574617693
430,WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,17,Down,0.494417486193392,0.938615574617693
431,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING,55,Down,0.497162082238506,0.938615574617693
432,WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE,33,Up,0.497487209742564,0.938615574617693
433,WP_UROTENSINIIMEDIATED_SIGNALING,50,Down,0.497907741423755,0.938615574617693
434,WP_P38_MAPK_SIGNALING,31,Down,0.498037200650696,0.938615574617693
435,WP_LUNG_FIBROSIS,34,Down,0.498960400298624,0.938615574617693
436,WP_BASE_EXCISION_REPAIR,29,Up,0.49904025348133,0.938615574617693
437,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,41,Down,0.501259023340066,0.938615574617693
438,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,74,Down,0.50216430124665,0.938615574617693
439,WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,10,Down,0.502496044822711,0.938615574617693
440,WP_NONHOMOLOGOUS_END_JOINING,10,Up,0.503263680978833,0.938615574617693
441,WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT,18,Up,0.503563830178105,0.938615574617693
442,WP_PDGF_PATHWAY,36,Down,0.504918188743093,0.939010749200956
443,WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1,21,Up,0.506468614435151,0.939767948229558
444,WP_PPARALPHA_PATHWAY,15,Up,0.508012348746014,0.940509348354107
445,WP_AEROBIC_GLYCOLYSIS,10,Down,0.511761438867361,0.941389339253227
446,WP_AEROBIC_GLYCOLYSIS_AUGMENTED,10,Down,0.511761438867361,0.941389339253227
447,WP_CYSTEINE_AND_METHIONINE_CATABOLISM,10,Down,0.51408110844739,0.941389339253227
448,WP_ONCOSTATIN_M_SIGNALING,56,Up,0.514438724073006,0.941389339253227
449,WP_MITOCHONDRIAL_FATTY_ACID_OXIDATION_DISORDERS,18,Down,0.515193859922882,0.941389339253227
450,WP_2Q13_COPY_NUMBER_VARIATION_SYNDROME,38,Down,0.515359127328409,0.941389339253227
451,WP_MRNA_VACCINE_ACTIVATION_OF_DENDRITIC_CELL_AND_INDUCTION_OF_IFN1,7,Up,0.516666337112854,0.941684543473982
452,WP_KLEEFSTRA_SYNDROME,25,Down,0.519407859007342,0.944586858637246
453,WP_WNT_SIGNALING_WP363,38,Up,0.521336950033798,0.945534503041758
454,WP_MRNA_PROCESSING,124,Up,0.523635993698342,0.945534503041758
455,WP_11P112_COPY_NUMBER_VARIATION_SYNDROME,37,Up,0.524023222366835,0.945534503041758
456,WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS,12,Up,0.52453008927864,0.945534503041758
457,WP_SEROTONIN_AND_ANXIETY,6,Down,0.529316710459219,0.946617282716254
458,WP_THYROXINE_THYROID_HORMONE_PRODUCTION,15,Up,0.529548432399532,0.946617282716254
459,WP_TROP2_REGULATORY_SIGNALING,42,Down,0.533141645204438,0.946617282716254
460,WP_ENDODERM_DIFFERENTIATION,82,Up,0.534255252616822,0.946617282716254
461,WP_IL10_ANTIINFLAMMATORY_SIGNALING,12,Up,0.536041711662843,0.946617282716254
462,WP_SULINDAC_METABOLIC_PATHWAY,2,Up,0.536265668598892,0.946617282716254
463,WP_STEROID_BIOSYNTHESIS,2,Down,0.537219612191716,0.946617282716254
464,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,10,Down,0.539892190404987,0.946617282716254
465,WP_PTF1A_RELATED_REGULATORY_PATHWAY,6,Down,0.540826081470463,0.946617282716254
466,WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,16,Down,0.542372615868053,0.946617282716254
467,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,59,Up,0.544012582137694,0.946617282716254
468,WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,31,Down,0.544786202175866,0.946617282716254
469,WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,7,Down,0.546103996859671,0.946617282716254
470,WP_GLYCOSAMINOGLYCAN_DEGRADATION,14,Down,0.546616778711125,0.946617282716254
471,WP_METHIONINE_DE_NOVO_AND_SALVAGE_PATHWAY,18,Up,0.546864294897515,0.946617282716254
472,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY,19,Up,0.547101131035499,0.946617282716254
473,WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,11,Down,0.549511030494672,0.946617282716254
474,WP_CANCER_PATHWAYS,308,Up,0.552845443210308,0.946617282716254
475,WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING,15,Down,0.553052528316389,0.946617282716254
476,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,28,Up,0.553329928210271,0.946617282716254
477,WP_BARDETBIEDL_SYNDROME,65,Up,0.55456534754621,0.946617282716254
478,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,10,Down,0.554755829739355,0.946617282716254
479,WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,7,Down,0.555584677874865,0.946617282716254
480,WP_INTRAFLAGELLAR_TRANSPORT_PROTEINS_BINDING_TO_DYNEIN,21,Down,0.558177281562538,0.946617282716254
481,WP_FOLATE_METABOLISM,40,Up,0.558588569970362,0.946617282716254
482,WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX,18,Down,0.558912181152251,0.946617282716254
483,WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,3,Up,0.55903733276955,0.946617282716254
484,WP_MICRORNA_NETWORK_ASSOCIATED_WITH_CHRONIC_LYMPHOCYTIC_LEUKEMIA,4,Up,0.559063207651815,0.946617282716254
485,WP_RUBINSTEINTAYBI_SYNDROME_1,12,Down,0.559688472386341,0.946617282716254
486,WP_VITAMIN_D_METABOLISM,6,Down,0.560037570388642,0.946617282716254
487,WP_BIOMARKERS_FOR_UREA_CYCLE_DISORDERS,4,Down,0.560830433920701,0.946617282716254
488,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,44,Down,0.565481668150859,0.952512154139357
489,WP_PENTOSE_PHOSPHATE_PATHWAY_IN_SENESCENT_CELLS,7,Up,0.5676534663371,0.953690456986025
490,WP_MEVALONATE_PATHWAY,7,Up,0.570064877926608,0.953690456986025
491,WP_MATRIX_METALLOPROTEINASES,8,Up,0.570115573057952,0.953690456986025
492,WP_PANCREATIC_CANCER_SUBTYPES,5,Down,0.573291612639045,0.953690456986025
493,WP_SPINAL_CORD_INJURY,67,Down,0.57373398900753,0.953690456986025
494,WP_GLUCOCORTICOID_BIOSYNTHESIS,6,Up,0.575848143836741,0.953690456986025
495,WP_LEUKOTRIENE_METABOLIC_PATHWAY,8,Down,0.577259059237927,0.953690456986025
496,WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS,81,Down,0.577400364857503,0.953690456986025
497,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,11,Down,0.577414698112222,0.953690456986025
498,WP_HEART_DEVELOPMENT,16,Up,0.578724393117209,0.953690456986025
499,WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,22,Down,0.578943476929472,0.953690456986025
500,WP_TRYPTOPHAN_CATABOLISM_LEADING_TO_NAD_PRODUCTION,13,Up,0.581443352471622,0.955184129522827
501,WP_HEDGEHOG_SIGNALING_WP4249,24,Down,0.582174268723767,0.955184129522827
502,WP_KININKALLIKREIN_PATHWAY,2,Up,0.586747835273184,0.960156177346521
503,WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,13,Up,0.589335331424477,0.960156177346521
504,WP_BDNFTRKB_SIGNALING,26,Up,0.592656534337765,0.960156177346521
505,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,37,Up,0.592790831841124,0.960156177346521
506,WP_METHYLATION_PATHWAYS,5,Down,0.596032596794759,0.960156177346521
507,WP_VITAMIN_B6DEPENDENT_AND_RESPONSIVE_DISORDERS,5,Up,0.600224402072717,0.960156177346521
508,WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA,11,Up,0.603083181436675,0.960156177346521
509,WP_INSULIN_SIGNALING,129,Down,0.608020562554605,0.960156177346521
510,WP_FARNESOID_X_RECEPTOR_PATHWAY,5,Up,0.609180323477345,0.960156177346521
511,WP_LDLRAD4_AND_WHAT_WE_KNOW_ABOUT_IT,7,Down,0.61007690527001,0.960156177346521
512,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,71,Up,0.610441107750553,0.960156177346521
513,WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,11,Up,0.612470552884157,0.960156177346521
514,WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION,10,Up,0.614894294485414,0.960156177346521
515,WP_EFFECT_OF_INTESTINAL_MICROBIOME_ON_ANTICOAGULANT_RESPONSE_OF_VITAMIN_K_ANTAGONISTS,5,Up,0.616603286354853,0.960156177346521
516,WP_FATTY_ACID_BIOSYNTHESIS,21,Down,0.616717316241207,0.960156177346521
517,WP_ACUTE_MYELOID_LEUKEMIA,55,Up,0.617250779649452,0.960156177346521
518,WP_MINERALOCORTICOID_BIOSYNTHESIS,5,Up,0.617629201142838,0.960156177346521
519,WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,10,Up,0.618017864538379,0.960156177346521
520,WP_BIOSYNTHESIS_AND_REGENERATION_OF_TETRAHYDROBIOPTERIN_AND_CATABOLISM_OF_PHENYLALANINE,6,Up,0.619260582015549,0.960156177346521
521,WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS,27,Down,0.619423042816505,0.960156177346521
522,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,11,Up,0.620428612986354,0.960156177346521
523,WP_NANOMATERIAL_INDUCED_APOPTOSIS,18,Down,0.622100412144747,0.960156177346521
524,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,20,Down,0.624290664032064,0.960156177346521
525,WP_MACROPHAGE_MARKERS,9,Down,0.624573578659467,0.960156177346521
526,WP_LIPID_PARTICLES_COMPOSITION,5,Up,0.626823926089573,0.960156177346521
527,WP_VITAMIN_D_RECEPTOR_PATHWAY,84,Down,0.627420430656502,0.960156177346521
528,WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING,5,Down,0.629133818570003,0.960156177346521
529,WP_GLUTATHIONE_METABOLISM,10,Down,0.630834649767189,0.960156177346521
530,WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2,44,Down,0.632219678121181,0.960156177346521
531,WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY,48,Down,0.632303218140777,0.960156177346521
532,WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP,49,Down,0.633160334268695,0.960156177346521
533,WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS,3,Down,0.634971444353649,0.960156177346521
534,WP_HORMONAL_CONTROL_OF_PUBERTAL_GROWTH_SPURT,1,Down,0.635624282517834,0.960156177346521
535,WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER,34,Up,0.635975655942951,0.960156177346521
536,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,8,Down,0.636504247822456,0.960156177346521
537,WP_PROTEASOME_DEGRADATION,57,Up,0.640919741896989,0.960156177346521
538,WP_2Q211_COPY_NUMBER_VARIATION_SYNDROME,8,Down,0.643105043486317,0.960156177346521
539,WP_HYPOTHETICAL_CRANIOFACIAL_DEVELOPMENT_PATHWAY,2,Down,0.643372980725844,0.960156177346521
540,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,40,Up,0.644703546819767,0.960156177346521
541,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,61,Up,0.645991648319958,0.960156177346521
542,WP_HIPPOYAP_SIGNALING,16,Down,0.650095199180846,0.960156177346521
543,WP_GLIOBLASTOMA_SIGNALING,68,Up,0.65014066895761,0.960156177346521
544,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING,168,Up,0.650869084503641,0.960156177346521
545,WP_GLYCOSPHINGOLIPID_METABOLISM,13,Down,0.651324192611484,0.960156177346521
546,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,51,Up,0.652083341895629,0.960156177346521
547,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,37,Down,0.652083783367321,0.960156177346521
548,WP_DOPAMINE_METABOLISM,7,Down,0.652300486294964,0.960156177346521
549,WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,31,Down,0.652602047326258,0.960156177346521
550,WP_NAD_BIOSYNTHETIC_PATHWAYS,20,Down,0.653211667096517,0.960156177346521
551,WP_NAD_BIOSYNTHESIS_II_FROM_TRYPTOPHAN,8,Up,0.653891037995463,0.960156177346521
552,WP_MOLYBDENUM_COFACTOR_MOCO_BIOSYNTHESIS,3,Down,0.656605819844808,0.960156177346521
553,WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES,272,Up,0.65720950241038,0.960156177346521
554,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,14,Down,0.659293922876634,0.960156177346521
555,WP_7Q1123_DISTAL_COPY_NUMBER_VARIATION,16,Up,0.662374394577628,0.960156177346521
556,WP_NF1_COPY_NUMBER_VARIATION_SYNDROME,64,Up,0.663089648701163,0.960156177346521
557,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,83,Down,0.665464119474591,0.960156177346521
558,WP_IL26_SIGNALING,33,Down,0.667500454332591,0.960156177346521
559,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,57,Up,0.667773669137659,0.960156177346521
560,WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS,24,Up,0.668170222503475,0.960156177346521
561,WP_NETRINUNC5B_SIGNALING,36,Up,0.668352285784625,0.960156177346521
562,WP_OMEGA9_FATTY_ACID_SYNTHESIS,10,Up,0.670240326262427,0.960156177346521
563,WP_VITAMIN_A1_AND_A5X_PATHWAYS,3,Down,0.674594045149124,0.960156177346521
564,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,23,Up,0.675185030240612,0.960156177346521
565,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,51,Up,0.677370721424243,0.960156177346521
566,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,11,Down,0.67964823531698,0.960156177346521
567,WP_IL9_SIGNALING,15,Up,0.681483312618702,0.960156177346521
568,WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,21,Up,0.684981762473604,0.960156177346521
569,WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER,85,Up,0.686892705957911,0.960156177346521
570,WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS,5,Up,0.687112721232418,0.960156177346521
571,WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,10,Up,0.68843516840029,0.960156177346521
572,WP_ACE_INHIBITOR_PATHWAY,3,Down,0.688671409538838,0.960156177346521
573,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,22,Down,0.690527478434504,0.960156177346521
574,WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY,25,Up,0.691483824567253,0.960156177346521
575,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,30,Down,0.692398831353609,0.960156177346521
576,WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN,19,Down,0.694591574226285,0.960156177346521
577,WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,12,Down,0.694840720523515,0.960156177346521
578,WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION,11,Down,0.695255402820485,0.960156177346521
579,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,51,Down,0.695728231811169,0.960156177346521
580,WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ,12,Down,0.696249078790306,0.960156177346521
581,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,18,Up,0.697632202427008,0.960156177346521
582,WP_SILDENAFIL_TREATMENT,11,Down,0.697644271125284,0.960156177346521
583,WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER,4,Up,0.698459505657288,0.960156177346521
584,WP_MONOAMINE_TRANSPORT,12,Down,0.699119521451141,0.960156177346521
585,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,20,Down,0.701030408685224,0.960156177346521
586,WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM,49,Down,0.701734240913737,0.960156177346521
587,WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,57,Up,0.702316115315122,0.960156177346521
588,WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS,22,Down,0.702915615927881,0.960156177346521
589,WP_KCNQ2RELATED_EPILEPSIES,12,Down,0.703066963201466,0.960156177346521
590,WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM,87,Up,0.704001805333551,0.960156177346521
591,WP_FATTY_ACID_BETAOXIDATION,29,Down,0.704588077119826,0.960156177346521
592,WP_GLUCURONIDATION,7,Down,0.705317462540153,0.960156177346521
593,WP_GLP1_SECRETION_FROM_INTESTINE_TO_PORTAL_VEIN,1,Down,0.705537347111866,0.960156177346521
594,WP_IL6_SIGNALING,40,Up,0.70587939543946,0.960156177346521
595,WP_SULFATION_BIOTRANSFORMATION_REACTION,6,Up,0.71058154591964,0.960156177346521
596,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,35,Up,0.712880433586792,0.960156177346521
597,WP_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION,9,Down,0.712998297340769,0.960156177346521
598,WP_INTERFERON_TYPE_I_SIGNALING,50,Up,0.715019932966092,0.960156177346521
599,WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT,10,Up,0.715076561410333,0.960156177346521
600,WP_EPO_RECEPTOR_SIGNALING,23,Up,0.715212784021676,0.960156177346521
601,WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES,1,Up,0.716102431199923,0.960156177346521
602,WP_CILIOPATHIES,127,Down,0.717495901089734,0.960156177346521
603,WP_JOUBERT_SYNDROME,70,Down,0.722043101610228,0.960156177346521
604,WP_PENTOSE_PHOSPHATE_METABOLISM,7,Down,0.722131785303296,0.960156177346521
605,WP_LEPTIN_SIGNALING,69,Down,0.722182601938922,0.960156177346521
606,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,14,Up,0.722739421272279,0.960156177346521
607,WP_RAS_SIGNALING,116,Down,0.723280538453819,0.960156177346521
608,WP_EBOLA_VIRUS_INFECTION_IN_HOST,106,Down,0.724915135103808,0.960156177346521
609,WP_1P36_COPY_NUMBER_VARIATION_SYNDROME,68,Down,0.725175134502184,0.960156177346521
610,WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS,12,Up,0.727059279208725,0.960156177346521
611,WP_METABOLIC_EPILEPTIC_DISORDERS,56,Down,0.727600055641381,0.960156177346521
612,WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN,16,Down,0.729434115927773,0.960156177346521
613,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,7,Down,0.729607649192002,0.960156177346521
614,WP_NONSMALL_CELL_LUNG_CANCER,59,Up,0.730478032862142,0.960156177346521
615,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,28,Down,0.732129479694199,0.960156177346521
616,WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,19,Down,0.732899766686783,0.960156177346521
617,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,37,Down,0.733866629439222,0.960156177346521
618,WP_CORI_CYCLE,11,Down,0.734183144257721,0.960156177346521
619,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,46,Down,0.734884467576143,0.960156177346521
620,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_AND_RESPIRATION,11,Down,0.735784496803745,0.960156177346521
621,WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING,25,Up,0.736073949848945,0.960156177346521
622,WP_G_PROTEIN_SIGNALING,61,Up,0.737406543713687,0.960156177346521
623,WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS,3,Down,0.737412452381281,0.960156177346521
624,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,62,Up,0.738224431275887,0.960156177346521
625,WP_EGFEGFR_SIGNALING,138,Down,0.738543303021076,0.960156177346521
626,WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,41,Up,0.740524769210761,0.960156177346521
627,WP_TOLLLIKE_RECEPTOR_SIGNALING,80,Down,0.741054346176882,0.960156177346521
628,WP_LACTATE_SHUTTLE_IN_GLIAL_CELLS,10,Down,0.74187374575846,0.960156177346521
629,WP_CILIARY_LANDSCAPE,184,Down,0.74201042505865,0.960156177346521
630,WP_15Q11Q13_COPY_NUMBER_VARIATION,31,Down,0.74349732606739,0.960156177346521
631,WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY,6,Down,0.744791118194928,0.960156177346521
632,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,30,Down,0.745166729171019,0.960156177346521
633,WP_INCLUSION_BODY_MYOSITIS,9,Down,0.74530362483938,0.960156177346521
634,WP_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER,11,Up,0.745446354318213,0.960156177346521
635,WP_IL11_SIGNALING,40,Down,0.746036111703632,0.960156177346521
636,WP_PERTURBATIONS_TO_HOSTCELL_AUTOPHAGY_INDUCED_BY_SARSCOV2_PROTEINS,40,Down,0.746991674363412,0.960156177346521
637,WP_DOPAMINERGIC_NEUROGENESIS,5,Up,0.749978994560375,0.960156177346521
638,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,19,Down,0.750004042706467,0.960156177346521
639,WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS,13,Up,0.750168429801917,0.960156177346521
640,WP_NANOMATERIALINDUCED_INFLAMMASOME_ACTIVATION,6,Down,0.75065708088724,0.960156177346521
641,WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,45,Down,0.751385548197145,0.960156177346521
642,WP_GASTRIC_CANCER_NETWORK_1,18,Down,0.752316482988568,0.960156177346521
643,WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME,48,Down,0.752658671294825,0.960156177346521
644,WP_FOXA2_PATHWAY,9,Up,0.754804194000869,0.960156177346521
645,WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS,3,Down,0.755106870105547,0.960156177346521
646,WP_PREIMPLANTATION_EMBRYO,20,Down,0.757376233647192,0.960156177346521
647,WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,10,Up,0.760515328147041,0.960156177346521
648,WP_COMPLEMENT_AND_COAGULATION_CASCADES,27,Down,0.760539840279229,0.960156177346521
649,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,27,Down,0.760539840279229,0.960156177346521
650,WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,9,Down,0.761522931137824,0.960156177346521
651,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3,27,Up,0.762585436963672,0.960156177346521
652,WP_MITOCHONDRIAL_COMPLEX_II_ASSEMBLY,8,Up,0.763706336761318,0.960156177346521
653,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,21,Up,0.764915288645975,0.960156177346521
654,WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,16,Down,0.765450365825433,0.960156177346521
655,WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,17,Up,0.767242722067044,0.960156177346521
656,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,67,Up,0.767422112878529,0.960156177346521
657,WP_FOXP3_IN_COVID19,10,Up,0.767424097952146,0.960156177346521
658,WP_ROBO4_AND_VEGF_SIGNALING_CROSSTALK,3,Up,0.769384150725325,0.961145549994251
659,WP_GASTRIC_CANCER_NETWORK_2,26,Up,0.771190358334131,0.961940022079902
660,WP_NUCLEAR_RECEPTORS_METAPATHWAY,179,Down,0.773786538912135,0.96233780101988
661,WP_GPCRS_CLASS_A_RHODOPSINLIKE,44,Down,0.775348024169915,0.96233780101988
662,WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT,7,Up,0.777518877303006,0.96233780101988
663,WP_HISTONE_MODIFICATIONS,37,Down,0.77772187035266,0.96233780101988
664,WP_ENDOTHELIN_PATHWAYS,13,Up,0.778337612705213,0.96233780101988
665,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,4,Down,0.778709051282454,0.96233780101988
666,WP_LUNG_PATHOLOGY_OF_COVID19,16,Down,0.781934983171966,0.96233780101988
667,WP_SARSCOV2_AND_COVID19_PATHWAY,6,Up,0.781972416966214,0.96233780101988
668,WP_PHOSPHOINOSITIDES_METABOLISM,38,Up,0.782920961198079,0.96233780101988
669,WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,16,Down,0.783216531486982,0.96233780101988
670,WP_WNT_SIGNALING_AND_PLURIPOTENCY,60,Up,0.785792271866741,0.963243699907917
671,WP_PEPTIDE_GPCRS,15,Down,0.786297472795879,0.963243699907917
672,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,6,Up,0.787608872938004,0.963379743063419
673,WP_ROS_IN_COVID19_ENDOTHELIAL_DYSFUNCTION,5,Down,0.788752514697908,0.963379743063419
674,WP_5Q35_COPY_NUMBER_VARIATION,76,Up,0.793028553278331,0.966921972318076
675,WP_ACETYLCHOLINE_SYNTHESIS,4,Up,0.795278599901565,0.966921972318076
676,WP_IRINOTECAN_PATHWAY,5,Down,0.795458285998805,0.966921972318076
677,WP_APOPTOSIS,72,Down,0.797344500369837,0.966921972318076
678,WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA,12,Up,0.798732073433818,0.966921972318076
679,WP_CARDIAC_HYPERTROPHIC_RESPONSE,44,Down,0.799616048192857,0.966921972318076
680,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,24,Down,0.800096482508275,0.966921972318076
681,WP_MAMMALIAN_DISORDER_OF_SEXUAL_DEVELOPMENT,2,Up,0.80160472139388,0.966921972318076
682,WP_CAMKK2_PATHWAY,29,Down,0.802401502461757,0.966921972318076
683,WP_NONCLASSICAL_ROLE_OF_VITAMIN_D,2,Up,0.80341570205991,0.966921972318076
684,WP_ALSTROM_SYNDROME,27,Up,0.805167688376448,0.967613800943626
685,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,27,Down,0.808950354077867,0.970740424893441
686,WP_PI3KAKT_SIGNALING,180,Up,0.812207051060857,0.972970866186135
687,WP_4P163_COPY_NUMBER_VARIATION,21,Down,0.813817915533905,0.972970866186135
688,WP_IL5_SIGNALING,37,Down,0.815900778478618,0.972970866186135
689,WP_ROLES_OF_CERAMIDES_IN_DEVELOPMENT_OF_INSULIN_RESISTANCE,16,Down,0.81613247612515,0.972970866186135
690,WP_2Q112_COPY_NUMBER_VARIATION_SYNDROME,22,Down,0.816727369426318,0.972970866186135
691,WP_ERBB_SIGNALING,67,Down,0.820097447238176,0.975571782387526
692,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION,9,Down,0.821598667020588,0.975634364276238
693,WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV,13,Down,0.824351408519862,0.975634364276238
694,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,61,Up,0.826405465908679,0.975634364276238
695,WP_IL4_SIGNALING,50,Down,0.827167891006867,0.975634364276238
696,WP_ANDROGEN_RECEPTOR_SIGNALING,78,Down,0.827371594136231,0.975634364276238
697,WP_TYROSINE_METABOLISM_AND_RELATED_DISORDERS,2,Up,0.834859155087385,0.975634364276238
698,WP_OXIDATIVE_STRESS_RESPONSE,21,Up,0.835070044598106,0.975634364276238
699,WP_NEUROINFLAMMATION,10,Down,0.835139912049786,0.975634364276238
700,WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES,21,Down,0.835644389920126,0.975634364276238
701,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,78,Up,0.836547824067964,0.975634364276238
702,WP_IL19_SIGNALING,20,Down,0.83766478972169,0.975634364276238
703,WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES,8,Down,0.839880368333696,0.975634364276238
704,WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,17,Up,0.84316688969417,0.975634364276238
705,WP_8Q1123_RB1CC1_COPY_NUMBER_VARIATION,16,Up,0.843796619452056,0.975634364276238
706,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,21,Up,0.844776559455669,0.975634364276238
707,WP_BILE_ACID_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,4,Up,0.844883529367529,0.975634364276238
708,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,29,Up,0.845515539061365,0.975634364276238
709,WP_GPCRS_OTHER,14,Down,0.845682632942932,0.975634364276238
710,WP_SEROTONIN_TRANSPORTER_ACTIVITY,4,Down,0.850160015323749,0.975634364276238
711,WP_HYPERTROPHY_MODEL,14,Up,0.851042400536681,0.975634364276238
712,WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS,2,Down,0.85335920968549,0.975634364276238
713,WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,33,Up,0.853884682697833,0.975634364276238
714,WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS,27,Up,0.858140566842083,0.975634364276238
715,WP_ATM_SIGNALING,34,Up,0.858219483609576,0.975634364276238
716,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING,41,Up,0.858457850868214,0.975634364276238
717,WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME,84,Up,0.858499065807478,0.975634364276238
718,WP_APOPTOSIS_MODULATION_BY_HSP70,17,Down,0.859410650203478,0.975634364276238
719,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,19,Down,0.859469346580828,0.975634364276238
720,WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,12,Down,0.859508433792007,0.975634364276238
721,WP_TCA_CYCLE_AND_DEFICIENCY_OF_PYRUVATE_DEHYDROGENASE_COMPLEX_PDHC,15,Up,0.859511485803487,0.975634364276238
722,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,65,Down,0.860245294218109,0.975634364276238
723,WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME,9,Up,0.861281266858052,0.975634364276238
724,WP_GABA_RECEPTOR_SIGNALING,9,Up,0.861771575938292,0.975634364276238
725,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,79,Down,0.862699419502123,0.975634364276238
726,WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1,7,Up,0.863670100103279,0.975634364276238
727,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,12,Up,0.864324252456461,0.975634364276238
728,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,23,Up,0.86475441343969,0.975634364276238
729,WP_CELL_DIFFERENTIATION_EXPANDED_INDEX,11,Down,0.866257456660194,0.975634364276238
730,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMMUNE_ACTIVATION,7,Up,0.86651240366108,0.975634364276238
731,WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT,47,Down,0.868296779833334,0.975634364276238
732,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,63,Down,0.870625833221888,0.975634364276238
733,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,33,Down,0.870834546300583,0.975634364276238
734,WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY,30,Up,0.876892638187242,0.975634364276238
735,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,40,Up,0.877604340154255,0.975634364276238
736,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,4,Up,0.879973840064166,0.975634364276238
737,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,60,Up,0.881391104753503,0.975634364276238
738,WP_VITAMIN_B12_METABOLISM,27,Up,0.881915214751558,0.975634364276238
739,WP_PROLACTIN_SIGNALING,69,Down,0.883218984563627,0.975634364276238
740,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING,142,Down,0.884052316632027,0.975634364276238
741,WP_ALANINE_AND_ASPARTATE_METABOLISM,5,Down,0.88613763292834,0.975634364276238
742,WP_KIT_RECEPTOR_SIGNALING,51,Up,0.8884055027809,0.975634364276238
743,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,23,Up,0.889620653101585,0.975634364276238
744,WP_BONE_MORPHOGENIC_PROTEIN_SIGNALING_AND_REGULATION,9,Up,0.88974941570868,0.975634364276238
745,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,15,Down,0.890666772596149,0.975634364276238
746,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,72,Down,0.891839581096793,0.975634364276238
747,WP_MAPK_CASCADE,30,Up,0.892197303225737,0.975634364276238
748,WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,43,Up,0.893698781791681,0.975634364276238
749,WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION,127,Up,0.894759769211653,0.975634364276238
750,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING,26,Up,0.894879790484863,0.975634364276238
751,WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS,17,Down,0.896053678242307,0.975634364276238
752,WP_TCELL_ACTIVATION_SARSCOV2,61,Down,0.896181048129942,0.975634364276238
753,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES,66,Up,0.898185231640943,0.975634364276238
754,WP_COVID19_AND_ENDOTHELIAL_CELL_SENESCENCE,4,Up,0.898623946518186,0.975634364276238
755,WP_PDGFRBETA_PATHWAY,27,Down,0.900341977694718,0.975634364276238
756,WP_PPAR_SIGNALING,39,Up,0.901358194886448,0.975634364276238
757,WP_AXON_GUIDANCE,37,Up,0.904308491841207,0.975634364276238
758,WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY,28,Down,0.904631677381702,0.975634364276238
759,WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION,23,Down,0.906635589406566,0.975634364276238
760,WP_HIPPO_SIGNALING_REGULATION,45,Up,0.90836933387618,0.975634364276238
761,WP_IL2_SIGNALING,37,Down,0.908983142739089,0.975634364276238
762,WP_NAD_METABOLISM,12,Down,0.909598289094995,0.975634364276238
763,WP_POSTCOVID_NEUROINFLAMMATION,13,Down,0.910795610909669,0.975634364276238
764,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,29,Down,0.911286769436298,0.975634364276238
765,WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER,36,Up,0.911610220416638,0.975634364276238
766,WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING,21,Down,0.912092114921906,0.975634364276238
767,WP_SMALL_CELL_LUNG_CANCER,71,Up,0.913205106732084,0.975634364276238
768,WP_AUTOPHAGY,27,Up,0.913670943469614,0.975634364276238
769,WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,21,Down,0.915331246536965,0.975634364276238
770,WP_COPPER_HOMEOSTASIS,40,Up,0.91617002896009,0.975634364276238
771,WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS,13,Up,0.916760894172224,0.975634364276238
772,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,30,Down,0.917990835476044,0.975634364276238
773,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,4,Up,0.918174671340257,0.975634364276238
774,WP_AMINO_ACID_METABOLISM,59,Up,0.91866301453748,0.975634364276238
775,WP_EICOSANOID_SYNTHESIS,13,Up,0.924805388191288,0.980890360120308
776,WP_SYNAPTIC_VESICLE_PATHWAY,20,Down,0.926047627033207,0.980942202862495
777,WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS,10,Down,0.927972409167271,0.981715984987769
778,WP_KETOGENESIS_AND_KETOLYSIS,5,Down,0.930942275201058,0.983591966857673
779,WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,15,Down,0.93254285985115,0.984018268032921
780,WP_CHOLESTEROL_BIOSYNTHESIS_WITH_SKELETAL_DYSPLASIAS,7,Up,0.935684878523567,0.98497818135132
781,WP_CELLULAR_PROTEOSTASIS,6,Up,0.936725589725771,0.98497818135132
782,WP_CHOLESTASIS,9,Up,0.937967625869089,0.98497818135132
783,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,8,Down,0.938743866086236,0.98497818135132
784,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,48,Down,0.940507128236359,0.98497818135132
785,WP_NEOVASCULARIZATION_PROCESSES,22,Up,0.941439087388025,0.98497818135132
786,WP_MIR124_PREDICTED_INTERACTIONS_WITH_CELL_CYCLE_AND_DIFFERENTIATION,5,Down,0.941840450781189,0.98497818135132
787,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING,11,Down,0.943238294297821,0.985186630130634
788,WP_ESTROGEN_METABOLISM_WP5276,8,Up,0.947651703487749,0.988540228765139
789,WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,16,Up,0.950819357236248,0.990072788020796
790,WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,14,Down,0.952888111363707,0.990072788020796
791,WP_GAMMAGLUTAMYL_CYCLE_FOR_THE_BIOSYNTHESIS_AND_DEGRADATION_OF_GLUTATHIONE_INCLUDING_DISEASES,4,Down,0.953700384446707,0.990072788020796
792,WP_NEPHROTIC_SYNDROME,28,Up,0.953938744662373,0.990072788020796
793,WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT,10,Down,0.962404777891126,0.996725848414422
794,WP_6Q16_COPY_NUMBER_VARIATION,5,Down,0.962774116351643,0.996725848414422
795,WP_CIRCADIAN_RHYTHM_GENES,121,Up,0.964459607524006,0.997214839477651
796,WP_TRANSSULFURATION_PATHWAY,8,Down,0.966539001638984,0.997407103187595
797,WP_NRF2_PATHWAY,73,Up,0.967668907464407,0.997407103187595
798,WP_16P112_PROXIMAL_DELETION_SYNDROME,62,Down,0.968285727912044,0.997407103187595
799,WP_BURN_WOUND_HEALING,60,Up,0.969556921827929,0.997466570391186
800,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,43,Up,0.970829259870687,0.997527064517131
801,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,11,Down,0.973663984867875,0.998466994450073
802,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,15,Down,0.974984919092332,0.998466994450073
803,WP_TYPE_III_INTERFERON_SIGNALING,7,Down,0.976859918585311,0.998466994450073
804,WP_PLEURAL_MESOTHELIOMA,257,Down,0.976927950463429,0.998466994450073
805,WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION,18,Up,0.977889006356776,0.998466994450073
806,WP_BLADDER_CANCER,29,Down,0.979271439563069,0.998466994450073
807,WP_LDL_INFLUENCE_ON_CD14_AND_TLR4,19,Down,0.983734813275273,0.998466994450073
808,WP_CELL_DIFFERENTIATION_INDEX,7,Down,0.986067059381827,0.998466994450073
809,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3,10,Down,0.989751200314745,0.998466994450073
810,WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA,9,Up,0.991475343139362,0.998466994450073
811,WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,17,Down,0.991891411621815,0.998466994450073
812,WP_PGK1_PKM2_KHKCKHKA_ACTING_AS_PROTEIN_KINASES,11,Down,0.99194400116685,0.998466994450073
813,WP_MEVALONATE_ARM_OF_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,12,Up,0.992082981973444,0.998466994450073
814,WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR,29,Up,0.992922657172931,0.998466994450073
815,WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,21,Down,0.99404040902191,0.998466994450073
816,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,9,Down,0.994123130879409,0.998466994450073
817,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,9,Down,0.994123130879409,0.998466994450073
818,WP_NODLIKE_RECEPTOR_NLR_SIGNALING,8,Down,0.994238472856913,0.998466994450073
819,WP_IRONSULFUR_CLUSTER_BIOGENESIS,15,Up,0.994822954324343,0.998466994450073
820,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,96,Down,0.996359471278271,0.998789616330169
821,WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMINO_ACIDS_AND_RELATED_DISORDERS,5,Up,0.999660746447622,0.999798276173066
822,WP_ESTROGEN_SIGNALING,21,Up,0.999798276173066,0.999798276173066
